Viewing Study NCT07160257

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:41 PM
Ignite Modification Date: 2025-12-29 @ 2:30 AM
Study NCT ID: NCT07160257
Status: RECRUITING
Last Update Posted: 2025-12-01
First Post: 2025-08-29
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Participants With Type 2 Diabetes Mellitus
Sponsor: Amgen
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes Mellitus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None T2DM View
None Type 2 Diabetes Mellitus View
None Maridebart Cafraglutide View
None AMG 133 View
None Insulin sensitivity View
None β-cell Function View